D&A
Flow – sum over the period · $M
Q4 2025
35.8a$M
derived
All values (10)
| Period | Value ($M) | Status |
|---|---|---|
| Q2 2026 | 33.6 | reported |
| Q1 2026 | 32.7 | reported |
| Q4 2025 | 35.8 | derived |
| Q3 2025 | 30.5 | reported |
| Q2 2025 | 31.4 | reported |
| Q1 2025 | 30.3 | reported |
| Q4 2024 | 31.1 | derived |
| Q3 2024 | 30.3 | reported |
| Q2 2024 | 30.2 | reported |
| Q1 2024 | 28.1 | reported |
| Q1 2016 – Q4 2023 | – | missing (32 periods): No verified SEC value extracted, although the company reports this metric in other periods. |
Show reported periods only · CSV with all sources · Technical ID: dna
More metrics for Teradyne
Income statement
Balance sheet
Debt and interest
Sources & calculation
- Value
- $36.0M (derived)
- Period
- Q4 2025, ended Dec 31, 2025 · quarterly value (3 months, not cumulative)
- Calculation
- Q4 = fiscal year − 9 months cumulative = 128M − 92M = $36.0M (FY value from 10-K 0001193125-26-059002; 9-month value from the Q3-10-Q)
- Source
- 10-K, filed Feb 19, 2026 · 0001193125-26-059002
- Location
- us-gaap:DepreciationDepletionAndAmortization
- Confidence
- 1. – directly from an XBRL fact in the filing (or calculated exactly from it)
Versions
| v1 | $36.0M | Feb 19, 2026 | 10-K 0001193125-26-059002 | derived · confidence 1. · current |